Research has revealed that in mesenchymal stem cells of COPD patients, the C-X-C motif ligand 12 (CXCL12)/C-X-C motif receptor 4 (CXCR4) chemokine axis was significantly inhibited10. This evidence concerns the gene CXCR4 and chronic obstructive pulmonary disease.